Cautious on US linked uncertainties, India’s pharma industry projected to grow between 7 -9 per cent in FY26: ICRA
Regulatory scrutiny by the US Food and Drug Administration (USFDA) is an ongoing risk factor | Photo Credit: Bogdanhoda Despite regulatory uncertainties and tariffs casting a shadow on pharma exports to the US, its largest export market, the Indian pharmaceutical…